Home › Funds › Legato Capital Management LLC › CORT
Legato Capital Management LLC position in CORT
CORCEPT THERAPEUTICS INC · Health Care
Legato Capital Management LLC reported holding 46,963 shares of CORT (CORCEPT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$5.4M, representing 0.52% of its reported portfolio and ranking #23 among its reported holdings. Legato Capital Management LLC has disclosed CORT holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Legato Capital Management LLC's CORT position evolved
Legato Capital Management LLC first disclosed a stake in CORT in Q3 2023 at 15,376 shares (US$419K). The position peaked in Q3 2026 at 46,963 shares, worth US$5.4M. Across 12 filings, Legato Capital Management LLC increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 46,963 shares valued at US$5.4M — an increase of 5,777 shares quarter over quarter.. Notable position changes include a 56% increase in Q2 2024 (shares rose 42% over the following quarter), a 50% trim in Q2 2025 (shares rose 13% over the following quarter), a 373% increase in Q2 2026 (shares rose 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 15.38K | $418.92K | New |
| Q4 2023 | 15.38K | $499.41K | Hold |
| Q1 2024 | 15.38K | $387.32K | Hold |
| Q2 2024 | 24.06K | $781.58K | Add |
| Q3 2024 | 34.04K | $1.58M | Add |
| Q4 2024 | 32.32K | $1.63M | Reduce |
| Q1 2025 | 27.98K | $3.20M | Reduce |
| Q2 2025 | 13.87K | $1.02M | Reduce |
| Q3 2025 | 17.98K | $1.49M | Add |
| Q1 2026 | 8.72K | $351.34K | New |
| Q2 2026 | 41.19K | $3.58M | Add |
| Q3 2026 | 46.96K | $5.41M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CORT and 13F data
CORT (CORCEPT THERAPEUTICS INC) is a Health Care company. 38 other funds we track also report a position in CORT — the largest reported positions include Renaissance Technologies (US$558.9M), Parallel Advisors, LLC (US$449.7M), TANG CAPITAL MANAGEMENT LLC (US$130.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CORT
- Renaissance Technologies 4.85M sh · $558.88M · Q3 2026
- Parallel Advisors, LLC 3.90M sh · $449.69M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $130.43M · Q2 2026
- EMERALD ADVISERS, LLC 758.26K sh · $87.37M · Q3 2026
- MPM BioImpact LLC 771.03K sh · $67.04M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 473.88K sh · $54.61M · Q3 2026
- PERCEPTIVE ADVISORS LLC 398.38K sh · $34.64M · Q2 2026
More on Legato Capital Management LLC
FAQ
How long has Legato Capital Management LLC held CORT?
Legato Capital Management LLC has disclosed CORT holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
What is Legato Capital Management LLC's current position in CORT?
As of Q3 2026, Legato Capital Management LLC holds 46.96K shares of CORT (CORCEPT THERAPEUTICS INC), valued at $5.41M, representing 0.52% of its reported portfolio and ranking #23.
Has Legato Capital Management LLC been buying or selling CORT?
In the latest 13F filing (Q3 2026), Legato Capital Management LLC increased its position in CORT. The position peaked in Q3 2026 at 46.96K shares.
Which other funds hold CORT?
Other major institutional holders of CORT include Renaissance Technologies, Parallel Advisors, LLC, TANG CAPITAL MANAGEMENT LLC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.